Airbus SE

  • WKN: 938914
  • ISIN: NL0000235190
  • Land: Niederlande

Nachricht vom 28.10.2021 | 06:29

Airbus SE: Airbus reports Nine-Month (9m) 2021 results

Airbus SE / Key word(s): Quarter Results
Airbus SE: Airbus reports Nine-Month (9m) 2021 results

28-Oct-2021 / 06:29 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Ad-hoc release, 28 October 2021

Airbus reports Nine-Month (9m) 2021 results

- 424 commercial aircraft delivered in 9m 2021

- 9m financials reflect deliveries as well as efforts on cost containment and competitiveness

- Revenues € 35.2 billion; EBIT Adjusted € 3.4 billion

- EBIT (reported) € 3.4 billion; EPS (reported) € 3.36

- Free cash flow before M&A and customer financing € 2.3 billion

- 2021 guidance unchanged for commercial aircraft deliveries, updated for EBIT Adjusted and FCF before M&A and customer financing

Airbus SE (stock exchange symbol: AIR) reported consolidated financial results for the nine months ended 30 September 2021.

"The nine-month results reflect a strong performance across the company as well as our efforts on cost containment and competitiveness. As the global recovery continues, we are closely monitoring potential risks to our industry. We are focused on securing the A320 Family ramp up and striving to ensure the right industrial and supply chain capabilities are in place," said Airbus Chief Executive Officer Guillaume Faury. "Based on our nine-month performance, we have updated our 2021 earnings and cash guidance. We are strengthening the balance sheet to secure investment for our long-term ambitions."

Gross commercial aircraft orders totalled 270 (9m 2020: 370 aircraft) with net orders of 133 aircraft after cancellations (9m 2020: 300 aircraft). The order backlog was 6,894 commercial aircraft on 30 September 2021. Airbus Helicopters booked 185 net orders (9m 2020: 143 units), including 10 helicopters of the Super Puma Family. Airbus Defence and Space's order intake by value was € 10.1 billion (9m 2020: € 8.2 billion) with third quarter orders including 56 C295 aircraft for India, two A400Ms for Kazakhstan and support and spares contract renewals for the German and Spanish Eurofighter fleets.

Consolidated revenues increased 17 percent to € 35.2 billion (9m 2020: € 30.2 billion), mainly reflecting the higher number of commercial aircraft deliveries compared to 9m 2020. A total of 424 commercial aircraft were delivered (9m 2020: 341 aircraft), comprising 34 A220s, 341 A320 Family, 11 A330s(1), 36 A350s and 2 A380s. Revenues generated by Airbus' commercial aircraft activities increased 21 percent, largely reflecting the delivery performance compared to 2020 which was strongly impacted by COVID-19. Airbus Helicopters delivered 194 units (9m 2020: 169 units) with revenues up 14 percent reflecting growth in services as well as the higher deliveries, notably more helicopters from the Super Puma family. Revenues at Airbus Defence and Space were broadly stable year-on-year with four A400M military airlifters delivered in 9m 2021.

Consolidated EBIT Adjusted - an alternative performance measure and key indicator capturing the underlying business margin by excluding material charges or profits caused by movements in provisions related to programmes, restructuring or foreign exchange impacts as well as capital gains/losses from the disposal and acquisition of businesses - was € 3,369 million (9m 2020: € -125 million).

The EBIT Adjusted related to Airbus' commercial aircraft activities totalled € 2,739 million (9m 2020: € -641 million), mainly driven by the operational performance linked to deliveries and efforts on cost containment and competitiveness.

The A220 production rate, which is currently at 5 aircraft a month, is expected to increase to around rate 6 per month in early 2022, with a monthly production rate of 14 envisaged by the middle of the decade. On the A320 Family programme, the Company is working to secure the ramp up and is on trajectory to achieve a monthly rate of 65 aircraft by summer 2023. The recent commercial successes of the A330 programme enable a monthly rate increase from around 2 to almost 3 aircraft at the end of 2022. The A350 programme is expected to increase from around 5 to around 6 aircraft a month in early 2023.

Airbus Helicopters' EBIT Adjusted increased to € 314 million (9m 2020: € 238 million), driven by services, programme execution and lower spending on Research & Development (R&D).

EBIT Adjusted at Airbus Defence and Space increased to € 284 million (9m 2020: € 266 million), mainly reflecting the Division's efforts on cost containment and competitiveness.

Consolidated self-financed R&D expenses totalled € 1,919 million (9m 2020: € 2,032 million).

Consolidated EBIT (reported) amounted to € 3,437 million (9m 2020: € -2,185 million), including net Adjustments of € +68 million.

These Adjustments comprised:
 

- € +190 million related to the A380 programme, of which € +45 million were booked in Q3;

- € -165 million related to the dollar pre-delivery payment mismatch and balance sheet revaluation, of which € +5 million were in Q3;

- € +43 million of other Adjustments, including compliance costs, of which € -6 million were in Q3.


The financial result was € -172 million (9m 2020: € -712 million). It mainly reflects the net interest result of € -233 million partly offset by € +63 million related to the revaluation of the Dassault Aviation equity stake. Consolidated net income(2) was € 2,635 million (9m 2020 net loss: € -2,686 million) with consolidated reported earnings per share of € 3.36 (9m 2020 loss per share: € -3.43).

Consolidated free cash flow before M&A and customer financing was € 2,260 million (9m 2020: € -11,798 million), reflecting efforts on cash containment and also included a positive phasing impact from working capital. Consolidated free cash flow was € 2,308 million (9m 2020: € -12,276 million).

On 30 September 2021, the gross cash position stood at € 21.7 billion (year-end 2020: € 21.4 billion) with a consolidated net cash position of € 6.7 billion (year-end 2020: € 4.3 billion). The Company's liquidity position remains strong, standing at € 27.7 billion at the end of September 2021. Given the increase in the net cash position and the robust liquidity, a decision was taken not to renew the undrawn € 6.2 billion Supplemental Liquidity Line which matured in September. In the meantime, the maturity of the € 6 billion Revolving Syndicated Credit Facility has been extended by a year.

Outlook
As the basis for its 2021 guidance, the Company assumes no further disruptions to the world economy, air traffic, the Company's internal operations, and its ability to deliver products and services.

The Company's 2021 guidance is before M&A.

On that basis, the Company has updated its 2021 guidance and now targets to achieve in 2021 around:
 

- 600 commercial aircraft deliveries;

- EBIT Adjusted of € 4.5 billion;

- Free Cash Flow before M&A and Customer Financing of € 2.5 billion.








 

Note to editors: Live Webcast of the Analyst Conference Call

At 08:15 CEST on 28 October 2021, you can listen to the 9m 2021 Results Analyst Conference Call with Chief Executive Officer Guillaume Faury and Chief Financial Officer Dominik Asam via the Airbus website https://www.airbus.com. The analyst call presentation can also be found on the website. A recording will be made available in due course. For a reconciliation of Airbus' KPIs to "reported IFRS" please refer to the analyst presentation.

Contacts for the media

Guillaume Steuer
Airbus
+33 (0) 6 73 82 11 68
Stefan Schaffrath
Airbus
+33 (0) 6 16 09 55 92
Justin Dubon
Airbus
+33 (0) 6 74 97 49 51
Martin Agüera
Airbus Defence and Space
+49 (0) 175 227 4369
Laurence Petiard
Airbus Helicopters
+33 (0) 6 18 79 75 69
Matthieu Duvelleroy
Airbus
+33 (0) 6 29 43 15 64
 


















Consolidated Airbus - Nine-Month (9m) 2021 Results

(Amounts in Euro)

Consolidated Airbus 9m 2021 9m 2020 Change
Revenues, in millions
thereof defence, in millions
35,155
6,577
30,161
6,116
+17%
+8%
EBIT Adjusted, in millions 3,369 -125 -
EBIT (reported), in millions 3,437 -2,185 -
Research & Development expenses, in millions 1,919 2,032 -6%
Net Income/Loss(2), in millions 2,635 -2,686 -
Earnings/Loss Per Share 3.36 -3.43 -
Free Cash Flow (FCF), in millions 2,308 -12,276 -
Free Cash Flow before M&A, in millions 2,322 -11,756 -
Free Cash Flow before M&A and Customer Financing, in millions 2,260 -11,798 -
 
Consolidated Airbus 30 Sept 2021 31 Dec 2020 Change
Net Cash position, in millions of Euro 6,733 4,312 +56%
Number of employees 125,888 131,349 -4%
 







 

 

By Business Segment Revenues EBIT (reported)
(Amounts in millions of Euro) 9m 2021 9m 2020 Change 9m 2021 9m 2020 Change
Airbus 24,618 20,271 +21% 2,889 -2,399 -
Airbus Helicopters 4,137 3,623 +14% 312 238 +31%
Airbus Defence and Space 6,881 6,936 -1% 204 -36 -
Eliminations -481 -669 - 32 12 +167%
Total 35,155 30,161 +17% 3,437 -2,185 -
 
By Business Segment EBIT Adjusted
(Amounts in millions of Euro) 9m 2021 9m 2020 Change
Airbus 2,739 -641 -
Airbus Helicopters 314 238 +32%
Airbus Defence and Space 284 266 +7%
Eliminations 32 12 +167%
Total 3,369 -125 -
 
By Business Segment Order Intake (net) Order Book
  9m 2021 9m 2020 Change 30 Sept 2021 30 Sept 2020 Change
Airbus, in units 133 300 -56% 6,894 7,441 -7%
Airbus Helicopters, in units 185 143 +29% 654 669 -2%
Airbus Defence and Space, in millions of Euro 10,134 8,214 +23% N/A N/A N/A
 

Consolidated Airbus - Third Quarter (Q3) 2021 Results

(Amounts in Euro)

Consolidated Airbus Q3 2021 Q3 2020 Change
Revenues, in millions 10,518 11,213 -6%
EBIT Adjusted, in millions 666 820 -19%
EBIT (reported), in millions 710 -626 -
Net Income/Loss(2), in millions 404 -767 -
Earnings/Loss Per Share 0.51 -0.98 -
 
By Business Segment Revenues EBIT (reported)
(Amounts in millions of
Euro)
Q3 2021 Q3 2020 Change Q3 2021 Q3 2020 Change
Airbus 6,805 7,738 -12% 502 -591 -
Airbus Helicopters 1,543 1,290 +20% 129 86 +50%
Airbus Defence and Space 2,343 2,385 -2% 47 -109 -
Eliminations -173 -200 - 32 -12 -
Total 10,518 11,213 -6% 710 -626 -
 
By Business Segment EBIT Adjusted
(Amounts in millions of Euro) Q3 2021 Q3 2020 Change
Airbus 448 666 -33%
Airbus Helicopters 131 86 +52%
Airbus Defence and Space 55 80 -31%
Eliminations 32 -12 -
Total 666 820 -19%
 

 

Q3 2021 revenues decreased 6 percent, mainly driven by lower commercial aircraft deliveries as well as less favourable foreign exchange rates, partially offset by higher revenues at Airbus Helicopters.

Q3 2021 EBIT Adjusted of € 666 million was mainly driven by the delivery performance. It also reflects the progressive resumption of activities.

Q3 2021 EBIT (reported) of € 710 million included net Adjustments of € +44 million. Net Adjustments in the third quarter of 2020 amounted to € -1,446 million.

Q3 2021 Net Income of € 404 million mainly reflects EBIT (reported), € -142 million from the financial result and € -183 million from income taxes.

EBIT (reported) / EBIT Adjusted Reconciliation

The table below reconciles EBIT (reported) with EBIT Adjusted.

Consolidated Airbus
(Amounts in millions of Euro)
9m 2021
EBIT (reported) 3,437
thereof:  
A380 programme +190
$ PDP mismatch/balance sheet revaluation -165
Others +43
EBIT Adjusted 3,369
 

 

Glossary

KPI DEFINITION
EBIT The Company continues to use the term EBIT (Earnings before interest and taxes). It is identical to Profit before finance result and income taxes as defined by IFRS Rules.
Adjustment Adjustment, an alternative performance measure, is a term used by the Company which includes material charges or profits caused by movements in provisions related to programmes, restructuring or foreign exchange impacts as well as capital gains/losses from the disposal and acquisition of businesses.
EBIT Adjusted The Company uses an alternative performance measure, EBIT Adjusted, as a key indicator capturing the underlying business margin by excluding material charges or profits caused by movements in provisions related to programmes, restructuring or foreign exchange impacts as well as capital gains/losses from the disposal and acquisition of businesses.
EPS Adjusted EPS Adjusted is an alternative performance measure of basic earnings per share as reported whereby the net income as the numerator does include Adjustments. For reconciliation, see the Analyst presentation.
Gross cash position The Company defines its consolidated gross cash position as the sum of (i) cash and cash equivalents and (ii) securities (all as recorded in the consolidated statement of financial position).
Net cash position For the definition of the alternative performance measure net cash position, see the Universal Registration Document, MD&A section 2.1.6.
FCF For the definition of the alternative performance measure free cash flow, see the Universal Registration Document, MD&A section 2.1.6.1. It is a key indicator which allows the Company to measure the amount of cash flow generated from operations after cash used in investing activities.
FCF before M&A Free cash flow before mergers and acquisitions refers to free cash flow as defined in the Universal Registration Document, MD&A section 2.1.6.1 adjusted for net proceeds from disposals and acquisitions. It is an alternative performance measure and key indicator that reflects free cash flow excluding those cash flows resulting from acquisitions and disposals of businesses.
FCF before M&A and customer financing Free cash flow before M&A and customer financing refers to free cash flow before mergers and acquisitions adjusted for cash flow related to aircraft financing activities. It is an alternative performance measure and indicator that may be used occasionally by the Company in its financial guidance, especially when there is higher uncertainty around customer financing activities.
 

Footnotes:

1. One A330 delivered on operating lease without revenue recognition at delivery.

2. Airbus SE continues to use the term Net Income/Loss. It is identical to Profit/Loss for the period attributable to equity owners of the parent as defined by IFRS Rules.

Safe Harbour Statement:

This press release includes forward-looking statements. Words such as "anticipates", "believes", "estimates", "expects", "intends", "plans", "projects", "may" and similar expressions are used to identify these forward-looking statements. Examples of forward-looking statements include statements made about strategy, ramp-up and delivery schedules, introduction of new products and services and market expectations, as well as statements regarding future performance and outlook.
By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.
These factors include but are not limited to:

- Changes in general economic, political or market conditions, including the cyclical nature of some of Airbus' businesses;

- Significant disruptions in air travel (including as a result of the spread of disease or terrorist attacks);

- Currency exchange rate fluctuations, in particular between the Euro and the U.S. dollar;

- The successful execution of internal performance plans, including cost reduction and productivity efforts;

- Product performance risks, as well as programme development and management risks;

- Customer, supplier and subcontractor performance or contract negotiations, including financing issues;

- Competition and consolidation in the aerospace and defence industry;

- Significant collective bargaining labour disputes;

- The outcome of political and legal processes, including the availability of government financing for certain programmes and the size of defence and space procurement budgets;

- Research and development costs in connection with new products;

- Legal, financial and governmental risks related to international transactions;

- Legal and investigatory proceedings and other economic, political and technological risks and uncertainties;

- The full impact of the COVID-19 pandemic and the resulting health and economic crisis.

As a result, Airbus SE's actual results may differ materially from the plans, goals and expectations set forth in such forward-looking statements.
For more information about the impact of the COVID-19 pandemic, see Note 2 "Impact of the COVID-19 pandemic" of the Notes to the Airbus SE Unaudited Condensed Interim IFRS Consolidated Financial Information for the nine-month period ended 30 September 2021. For more information about factors that could cause future results to differ from such forward-looking statements, see Airbus SE's annual reports, including its 2020 Universal Registration Document and the most recent Risk Factors.
Any forward-looking statement contained in this press release speaks as of the date of this press release. Airbus SE undertakes no obligation to publicly revise or update any forward-looking statements in light of new information, future events or otherwise.
Rounding
Due to rounding, numbers presented may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.


28-Oct-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Neufassung der Dividendenpolitik der Allianz SE

02. Dezember 2021, 20:33

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021